日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort Study

亚胺培南-西司他丁-瑞巴坦在现实世界中的应用：一项多中心观察性队列研究的启示

期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofaf112
Caniff, Kaylee E; Rebold, Nicholas; Xhemali, Xhilda; Tran, Nikki; Eubank, Taryn A; Garey, Kevin W; Guo, Yi; Chang, Mei; Barber, Katie E; Krekel, Tamara; Biagi, Mark; Kufel, Wesley D; Carr, Amy; Hayes, Jillian; Carlson, Travis J; Frens, Jeremy; Venugopalan, Veena; Lucas, Kristen; Kunz Coyne, Ashlan J; Sanders, James; Chandler, Elisabeth; Li, Rosanna; Antosz, Kayla; Justo, Julie Ann; Benefield, Russell; Moore, W Justin; Ross, Jennifer; Adams, Jenna; Albarillo, Fritzie; Stefanos, Sylvia; Hobbs, Athena L V; Mercuro, Nicholas; Raux, Brian; Zeitler, Kristen; Rybak, Michael J
发表日期：2025
文献求助 收藏

Factors and Disparities Influencing Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide 1 Receptor Agonists Initiation in the United States: A Scoping Review of Evidence

影响美国钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽-1受体激动剂起始治疗的因素和差异：证据范围综述

期刊:
影响因子:
doi:10.3390/pharmacy13020046
Moore, Josiah; Iheme, Ndidi; Rebold, Nicholas S; Kusi, Harriet; Mere, Constance; Nwaogwugwu, Uzoamaka; Ettienne, Earl; Chaijamorn, Weerachai; Rungkitwattanakul, Dhakrit
信号转导
发表日期：2025
文献求助 收藏

Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study

达巴万星序贯疗法治疗革兰氏阳性菌血流感染：一项多中心观察性研究

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-024-00933-2
Rebold, Nicholas; Alosaimy, Sara; Pearson, Jeffrey C; Dionne, Brandon; Taqi, Ahmad; Lagnf, Abdalhamid; Lucas, Kristen; Biagi, Mark; Lombardo, Nicholas; Eudy, Joshua; Anderson, Daniel T; Mahoney, Monica V; Kufel, Wesley D; D'Antonio, Joseph A; Jones, Bruce M; Frens, Jeremy J; Baumeister, Tyler; Geriak, Matthew; Sakoulas, George; Farmakiotis, Dimitrios; Delaportas, Dino; Larew, Jeremy; Veve, Michael P; Rybak, Michael J
炎症/感染
流感
微生物学
发表日期：2024
文献求助 收藏

High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production

高剂量头孢吡肟与碳青霉烯类药物治疗由肠杆菌科细菌引起的菌血症（伴有中度至高度临床显著AmpC β-内酰胺酶产生风险）的疗效比较

期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofad034
Kunz Coyne, Ashlan J; El Ghali, Amer; Lucas, Kristen; Witucki, Paige; Rebold, Nicholas; Holger, Dana J; Veve, Michael P; Rybak, Michael J
微生物学
发表日期：2023
文献求助 收藏

Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure

碳青霉烯类耐药肠杆菌临床治疗失败的风险因素

期刊:Microbiology Spectrum
影响因子:3.8
doi:10.1128/spectrum.02647-22
Rebold, Nicholas; Lagnf, Abdalhamid M; Alosaimy, Sara; Holger, Dana J; Witucki, Paige; Mannino, Andrew; Dierker, Michelle; Lucas, Kristen; Kunz Coyne, Ashlan J; El Ghali, Amer; Caniff, Kaylee E; Veve, Michael P; Rybak, Michael J
发表日期：2023
文献求助 收藏

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa

针对新出现的多重耐药铜绿假单胞菌的治疗策略

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-022-00591-2
Kunz Coyne, Ashlan J; El Ghali, Amer; Holger, Dana; Rebold, Nicholas; Rybak, Michael J
发表日期：2022
文献求助 收藏

Clinical Characteristics Associated with Bacterial Bloodstream Coinfection in COVID-19

COVID-19合并细菌性血流感染的临床特征

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-022-00636-6
Rebold, Nicholas; Alosaimy, Sara; Morrisette, Taylor; Holger, Dana; Lagnf, Abdalhamid M; Ansari, Iman; Belza, Ana C; Cheaney, Laura; Hussain, Huzaifa; Herbin, Shelbye R; Abdul-Mutakabbir, Jacinda; Carron, Caitlin; Sandhu, Avnish; Chopra, Teena; Rybak, Michael J
炎症/感染
流感
微生物学
发表日期：2022
文献求助 收藏

Impact of Ceftolozane-Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections

头孢洛扎-他唑巴坦与最佳替代疗法对多重耐药和广泛耐药铜绿假单胞菌下呼吸道感染患者临床结局的影响

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-022-00687-9
Holger, Dana J; Rebold, Nicholas S; Alosaimy, Sara; Morrisette, Taylor; Lagnf, Abdalhamid; Belza, Ana Christine; Coyne, Ashlan J Kunz; El Ghali, Amer; Veve, Michael P; Rybak, Michael J
炎症/感染
发表日期：2022
文献求助 收藏

COVID-19: Before the Fall, An Evidence-Based Narrative Review of Treatment Options

COVID-19：疫情爆发前，基于证据的治疗方案叙述性综述

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-021-00399-6
Rebold, Nicholas; Holger, Dana; Alosaimy, Sara; Morrisette, Taylor; Rybak, Michael
发表日期：2021
文献求助 收藏

Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections

亚胺培南-西司他丁-瑞巴坦治疗多重耐药革兰氏阴性菌感染的早期多中心经验

期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofab554
Rebold, Nicholas; Morrisette, Taylor; Lagnf, Abdalhamid M; Alosaimy, Sara; Holger, Dana; Barber, Katie; Justo, Julie Ann; Antosz, Kayla; Carlson, Travis J; Frens, Jeremy J; Biagi, Mark; Kufel, Wesley D; Moore, William J; Mercuro, Nicholas; Raux, Brian R; Rybak, Michael J
炎症/感染
发表日期：2021
文献求助 收藏